Login

Hendrik Bischof from HUBER+SUHNER discusses his role in Group Strategy and M&A and his experiences working at the company. 00:10:00

Share On Facebook Share On Twitter

Urs Ryffel is Chief Executive Officer, Huber + Suhner AG.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:00:00
Moberg Pharma | Interview - Anna Ljung, CEO, Moberg Pharma AB (publ)
00:10:00
investing from the earliest seeds of startup life to businesses scaling for growth|Ben Savage,Partner,Clocktower Technology Ventures
00:10:00
Intrepid Metals Corp CEO Ken Brophy discusses the company's move to OTCQB, progress on the Corral Copper project, and ambitious plans for exploration and expansion in Arizona's mining-rich regions.|Ken Brophy CEO of Intrepid Metals Corp.
00:10:00
Stephen Manderson, aka Professor Green, interviews Centrica CEO Chris O'Shea and CEO of the British Gas Energy Trust Jessica Taplin to discuss energy initiatives.
00:10:00
"Understanding Canadian Consumer Debt and Subscriptions with Elizabeth Naumovski"
00:10:00
Plateau Uranium: Leading Lithium-Uranium Exploration in Peru, Fueling Green Energy Future
00:10:00
CynergisTek: Leading Healthcare Cybersecurity with Mac McMillan, Founder and CEO | Mac McMillan, CEO and President, CynergisTek Inc CTEK:ASQ
00:10:00
AI in Travel: Jane Sun on Transforming the Industry at Trip.com | Morgan Stanley
00:10:00
The cold and dark Helsinki welcomed these tech-heads|Amitt Mahajan,Managing Partner,Presence Capital
00:10:00
Building a Legacy: Reflections on 30 Years in Money Management | Mark Okada, CIO,  Highland Capital Management .
00:10:00
Miguel Stilwell d'Andrade, CEO at EDP, discusses the company's commitments to net zero and the challenges associated with the energy transition.
00:10:00
Focused solely on private equity|Saurabh Agarwal,Managing Director,Warburg Pincus LLC

© 2026 Nehu